CLEOMICS develops AI-powered liquid biopsy tests based on extrachromosomal circular DNA (eccDNA) to enable early cancer detection and treatment monitoring.
Septembre 2026
FR - Occitanie
DM/DIV
Laboratory POC
.png)
